Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction
Rhea-AI Summary
Avalon GloboCare (NASDAQ: ALBT) acquired RPM Interactive in an all-stock merger completed Dec. 12, 2025, effected by merging RPM into newly formed subsidiary Avalon Quantum AI, LLC.
Avalon issued 19,500 shares of Series E preferred (stated value $1,000/share; total purchase price $19.5 million) convertible at $1.50/share subject to a 4.99% ownership cap and conversion restrictions until May 12, 2026 and shareholder approval requirements. The company said this transaction brings stockholders’ equity above the $2.5 million Nasdaq minimum. RPM’s Catch-Up SaaS short-form generative AI video platform will support marketing for KetoAir™ and other consumer products.
Positive
- $19.5M consideration issued as Series E preferred stock
- Company believes stockholders’ equity exceeds the $2.5M Nasdaq minimum
- Catch-Up SaaS targeted for immediate marketing after the new year
- Appointment of Michael Mathews to Avalon’s Board
Negative
- Series E conversions restricted until May 12, 2026 and need shareholder approval
- Conversion price of $1.50 could cause dilution upon conversion
- Company’s Nasdaq compliance described as a belief, not a final regulator order
News Market Reaction
On the day this news was published, ALBT declined 24.63%, reflecting a significant negative market reaction. Argus tracked a peak move of +6.1% during that session. Argus tracked a trough of -49.7% from its starting point during tracking. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $6M at that time. Trading volume was exceptionally heavy at 23.2x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Momentum scanner showed only RFL moving up (+7.88%) with no news, while sector peers like LRHC and DUO showed individual declines, indicating stock-specific rather than broad sector-driven dynamics.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 01 | KetoAir progress | Positive | -8.1% | KetoAir Q3 progress including UK launch and Nevada first-responder data. |
| Aug 28 | UK product launch | Positive | +2.9% | Announcement of KetoAir online sales launch in the United Kingdom. |
| Jul 28 | Distribution deal | Positive | +30.8% | Distribution agreement with Saga Health for KetoAir targeting first responders. |
| Jul 14 | Patent issuance | Positive | +6.3% | New Hong Kong patent for CAR-T and CAR-NK bispecific cell technology. |
| Jun 26 | New collaboration | Positive | +0.9% | Definitive agreement with Qi Diagnostics to co-develop cannabis breathalyzer. |
Positive product and partnership updates have often seen aligned positive price reactions, while one prior positive news event drew a negative move, showing occasional sell-the-news behavior.
Over the last six months, Avalon reported multiple developments around KetoAir™ launches, distribution, and holistic health programs, plus a new CAR-T/CAR-NK patent and a cannabis breathalyzer collaboration. These announcements generally carried positive operational tone, with four of five events showing positive 24-hour price reactions up to +30.84%. One Q3 KetoAir™ progress update on Dec 01, 2025 coincided with a -8.11% move, indicating that favorable updates have not always translated into short-term gains.
Market Pulse Summary
The stock dropped -24.6% in the session following this news. A negative reaction despite strategic AI expansion fits past patterns where positive news did not always support the stock, as with the Dec 01, 2025 KetoAir™ progress update that saw a -8.11% move and the YOOV merger’s -24.07% response. The company’s prior equity deficiency highlighted in Nasdaq notices and its history of losses and complex financing may heighten concern around additional stock issuance and integration risk, contributing to downside pressure.
Key Terms
generative AI technical
saas technical
convertible preferred stock financial
beneficial ownership limitation financial
nasdaq listing rules regulatory
s-4 registration statement regulatory
AI-generated analysis. Not financial advice.
Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition
Acquisition expected to resolve Nasdaq minimum stockholders’ equity deficiency
RPM Interactive has developed a fully automated, generative AI powered SaaS platform for creating short-form video content
FREEHOLD, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it has acquired RPM Interactive, Inc. (“RPM”), a generative artificial intelligence (“AI”) publishing and software company, in an all-stock transaction. As a result of the acquisition, the Company believes its stockholders’ equity now exceeds the
Under the terms of the Agreement and Plan of Merger dated December 12, 2025 by and among the Company, Avalon Quantum AI, LLC and RPM (the “Merger Agreement”), RPM merged with and into Avalon Quantum AI, LLC, a wholly-owned subsidiary of the Company (the “Merger”). In connection with the Merger, Avalon issued 19,500 shares of Series E Non-Voting Convertible Preferred Stock (“Series E Preferred Stock”) to RPM’s stockholders, representing a total purchase price of
RPM has developed the Catch-Up Software-as-a-Service (SaaS) platform, a system that intelligently sources relevant video clips, generates human-like AI commentary, creates an engaging on-screen avatar, and publishes finished content to all major platforms – all on an automated basis. Marketing for this software platform is expected to begin immediately after the new year.
The Catch-Up SaaS platform is expected to be licensed to successful content creators, media companies, and brands to efficiently generate recap-style videos across news, politics, sports, finance, entertainment, and other evergreen categories—without requiring manual editing, production tools, or technical expertise. This new, unique video format has been designed to give successful content creators a second video format to publish with, driving up their volume of videos produced each week and revenues.
Avalon plans to leverage the Catch-Up platform to support and amplify marketing initiatives for KetoAir™, the Company’s FDA-registered breathalyzer designed to help consumers easily monitor and manage their wellness and metabolic health. The pairing of Avalon's consumer health products with RPM’s AI-driven content engine is expected to accelerate audience reach, digital engagement, and adoption of Avalon's product portfolio.
“The acquisition of RPM is an important strategic step for Avalon,” said Meng Li, Interim Chief Executive Officer and Chief Operating Officer of Avalon GloboCare. “Integrating RPM’s AI-driven video studio with our consumer health products, starting with the launch of KetoAir™, will enhance our marketing capabilities, broaden our digital reach, and support our long-term value creation strategy. We look forward to leveraging RPM’s technology to elevate our brand visibility and strengthen our position in the precision wellness market.”
“RPM’s Catch-Up SaaS platform represents a breakthrough in how short-form video content can be created, scaled, and monetized,” said Michael Mathews, Chief Executive Officer of RPM. “By leveraging our fully automated generative AI video studio to support the marketing and efforts behind Avalon’s KetoAir™, we believe we can significantly enhance digital engagement and create new opportunities to reach health and wellness-focused consumers.”
Pursuant to the Merger Agreement, Michael Mathews has been appointed to Avalon's Board of Directors. Michael Mathews is a seasoned technology and digital media executive with more than two decades of leadership experience across AI, internet services, digital marketing, and online learning sectors. He currently serves as Chairman and Chief Executive Officer of Aspen Group, Inc. (OTCQB: ASPU), which owns Aspen University and United States University. ASPU holds a unique position in the higher education sector, as they uniquely offer students monthly payment plans allowing students the ability to graduate debt free.
Previously, Mr. Mathews served as Chief Executive Officer and Director of Interclick, Inc., a data-driven digital advertising technology company. Under his leadership, Interclick became a category leader and was acquired by Yahoo, Inc. in 2011.
Earlier in his career, Mr. Mathews held senior leadership roles including Senior Vice President of Marketing and Publisher Services at World Avenue U.S.A., LLC, where he oversaw strategic marketing, publisher development, and large-scale digital distribution initiatives.
“Michael is a recognized innovator in performance marketing and AI-enabled content systems,” added Meng Li, Interim Chief Executive Officer and Chief Operating Officer of Avalon GloboCare. “He brings deep experience in scaling technology platforms, driving digital engagement, and building long-term shareholder value. We are pleased to welcome him to our Board as we execute on our growth and technology integration strategy.”
E.F. Hutton & Co. served as financial advisor to RPM Interactive, Inc. in connection with the transaction.
The Company also has a pending merger with YOOV Group Holdings Limited, a provider of advanced artificial intelligence automation solutions and currently has an S-4 registration statement on file with the Securities and Exchange Commission that was originally filed April 29, 2025.
About KetoAir ™
KetoAir™ is a handheld breathalyzer designed for ketogenic health management (U.S. Food and Drug Administration registration number: 3026284320). It measures breath acetone concentration (BrAce), a key indicator of fat metabolism and ketosis. The KetoAir™ breathalyzer device is owned and manufactured by Qi Diagnostics Limited, a nanosensor-based diagnostic technologies company. Intended for users pursuing ketogenic diets for weight loss, athletic performance, or therapeutic purposes, the device utilizes nano-sensor technology to provide real-time insights. KetoAir™ is compatible with both Apple and Android devices and is available via the Apple App Store and Google Play Store. For more information or to purchase KetoAir™, please visit www.ketoair.us.
About Avalon GloboCare Corp.
Avalon GloboCare Corp. (NASDAQ: ALBT) is a developer of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. Avalon is currently marketing the KetoAir™ breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAirTM is registered with the U.S. Food and Drug Administration as a Class I medical device. The Company also continues to focus on advancing its intellectual property portfolio through existing patent applications. In addition, Avalon owns and operates commercial real estate.
For more information about Avalon, please visit www.avalon-globocare.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.
No Offer or Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any proxy, consent, authorization, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”).
Additional Information About the Proposed Merger for Investors and Shareholders
This communication relates to the proposed merger (the “proposed Merger”) of Avalon and YOOV Group Holding Limited (“YOOV”). In connection with the proposed Merger, Avalon has filed relevant materials with the U.S. Securities and Exchange Commission (the “SEC”), including a Registration Statement on Form S-4, as amended, that contains a preliminary prospectus and preliminary proxy statement of Avalon (the “proxy statement/prospectus”). This Registration Statement has not yet been declared effective and Avalon has filed or may file other documents regarding the proposed Merger with the SEC. This press release is not a substitute for the proxy statement/prospectus or for any other document that Avalon has filed or may file with the SEC in connection with the proposed Merger. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY, WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING THE PROPOSED MERGER. A definitive proxy statement/prospectus will be sent to Avalon’s stockholders. Investors and security holders will be able to obtain these documents (when available) free of charge from the SEC’s website at www.sec.gov. In addition, investors and stockholders should note that Avalon communicates with investors and the public using its website (https://www.avalon-globocare.com), the investor relations website (https://www.avalon-globocare.com/investors) where anyone will be able to obtain free copies of the proxy statement/prospectus and other documents filed by Avalon with the SEC, and stockholders are urged to read the proxy statement/prospectus and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed Merger.
Participants in the Solicitation
Avalon, YOOV and their respective directors and executive officers and other members of management and employees and certain of their respective significant stockholders may be deemed to be participants in the solicitation of proxies from Avalon and YOOV stockholders in respect of the proposed Merger. Information about Avalon’s directors and executive officers is available in Avalon’s Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on March 31, 2025. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the proxy solicitation and a description of their direct and indirect interests, by security holding or otherwise, has been and will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed Merger when they become available. Investors should read the definitive proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the SEC and Avalon as indicated above.
Forward-Looking Statements
Certain statements contained in this press release are “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will”, “anticipate”, “estimate”, “expect”, “should”, “may”, and other words and terms of similar meaning or use of future dates; however, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding the ability to enter into a definitive agreement, as well as the Company’s commercialization, distribution and sales of its products and the product’s ability to compete with other similar products. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission (the “SEC”), accessible through the SEC’s website (http://www.sec.gov), including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed or furnished with the SEC. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. The Company disclaims any obligation to update forward-looking statements. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. The contents of any website referenced in this press release are not incorporated by reference herein.
Contact Information:
Avalon GloboCare Corp.
4400 Route 9 South, Suite 3100
Freehold, NJ 07728
PR@Avalon-GloboCare.com
Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
albt@crescendo-ir.com